Katherine Andrade

机构：Optum (United States) · ORCID：0000-0002-5966-1140

发表论文 45 篇 · 总被引 129 次 · h-index 6

代表论文

• Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment (2022 · JAMA Network Open · 被引 27)
• The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl (2022 · American Journal of Preventive Cardiology · 被引 8)
• PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischaemic events: an observational study (2026 · European Heart Journal · 被引 3)
• Quality of life post heart failure diagnosis: population-level trends in the U.S. (2025 · Health and Quality of Life Outcomes · 被引 3)
• Cost of disease progression among US patients with human epidermal growth factor receptor 2-positive metastatic breast cancer (2024 · Journal of Comparative Effectiveness Research · 被引 3)
• Prevalence and mortality rate of heart failure across demographic groups in the United States: 2001–2020 (2025 · American Heart Journal Plus Cardiology Research and Practice · 被引 2)